Assessment of bone-targeting agents use in patients with bone metastasis from breast, lung or prostate cancer using structured and unstructured electronic health records from a regional UK-based hospital.
Anouchka SeesaghurPeter EggerJoshua WardenAli AbbasiBethany LevickMajid RiazPeter McMahonMatthew ThompsonSue CheesemanPublished in: BMJ open (2023)
In this study identifying BM diagnosis from both structured and unstructured data, a high proportion of patients did not receive a BTA. Unstructured data provide new insights on the real-world use of BTA.
Keyphrases
- electronic health record
- prostate cancer
- adverse drug
- end stage renal disease
- clinical decision support
- bone mineral density
- newly diagnosed
- ejection fraction
- healthcare
- chronic kidney disease
- prognostic factors
- emergency department
- soft tissue
- peritoneal dialysis
- patient reported outcomes
- big data
- bone regeneration
- patient reported